In 2019, the agency introduced its Technology Modernization Action Plan (TMAP), a program designed to bring the organization up to speed with the latest technologies in order to expedite breakthrough discoveries with the intent
of improving public health.
This publication provides an in-depth look at the FDA’s transformation and addresses how the agency’s initiative will impact manufacturers of regulated products.